The hottest Pharmaceutical industry Substack posts right now

And their main takeaways
Category
Top Business Topics
BIG by Matt Stoller 56953 implied HN points 26 Dec 23
  1. The pharmaceutical industry is heavily influenced by aggressive marketing campaigns targeted at doctors, controlled by corporations like IQVIA.
  2. IQVIA, a major player in the healthcare industry, is involved in a trial over a merger that could impact the future of advertising to healthcare professionals.
  3. The FTC alleges that IQVIA's acquisition of advertising firms like DeepIntent could lead to a monopolization of the healthcare provider advertising platform market.
uTobian 8235 implied HN points 06 Feb 24
  1. Enclosure historically happens under any system that wants to industrialize.
  2. Pharma has captured the state through various acts and profits from selling treatments for vaccine injuries.
  3. Covid represents an extreme form of enclosure by the ruling class for profit, through actions like vaccine mandates.
RESCUE with Michael Capuzzo 1965 implied HN points 09 Feb 24
  1. The article highlights concerns about the safety and effectiveness of Paxlovid as doctors start to drop it due to drug interactions and research linking it to Covid rebounds and virus shedding.
  2. Pfizer is heavily promoting Paxlovid amidst concerns, transitioning from Emergency Use Authorization to FDA approval at a much higher price, despite struggles to market the drug successfully.
  3. There is a push to stigmatize skeptics of Paxlovid as 'anti-paxxers,' paralleling previous campaigns against alternative treatments like ivermectin.
Alexander News Network -Dr. Paul Elias Alexander's substack 1277 implied HN points 11 Feb 24
  1. Dr. Yeadon points out potential toxicity mechanisms in COVID vaccines based on his toxicology expertise and industry experience.
  2. Different mechanisms of toxicity in COVID vaccines were identified, which wouldn't be overlooked in typical drug development processes.
  3. Open letter to the European Medicines Agency highlighted concerns about potential harms from mass vaccine administration, with subsequent validations.
Weight and Healthcare 838 implied HN points 21 Feb 24
  1. Medicare Part D plans are prohibited from covering weight loss medications by a law passed in 2003.
  2. The weight loss industry, led by pharma companies like Novo Nordisk, aims to get Part D coverage of these drugs, which could lead to significant costs for Medicare.
  3. Studies show that weight loss interventions in older adults can have negative health impacts, including increased mortality risk, muscle loss, and frailty.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
Weight and Healthcare 639 implied HN points 04 Mar 23
  1. The Obesity Action Coalition (OAC) is not an advocacy group for higher-weight people, but predominantly funded by and lobbies for the priorities of the weight loss industry.
  2. OAC's priorities aim to expand Medicare coverage for weight loss interventions, revealing ties to the weight loss industry such as funding from companies producing weight loss drugs and surgical equipment.
  3. There are parallels between OAC's actions and the tactics used by pharmaceutical companies in the past, like Purdue Pharma, to influence healthcare organizations and profit from weight loss interventions.
eugyppius: a plague chronicle 353 implied HN points 23 Apr 23
  1. German reporting is focusing more on vaccine injuries from mRNA jabs.
  2. This shift has been driven by popular interest, contrary to previous enthusiasm for vaccines.
  3. The pharmaceutical industry's profits have not matched the success of their mRNA vaccines.
Weight and Healthcare 419 implied HN points 13 Jul 22
  1. The article discusses the debate over whether Type 2 Diabetes management should prioritize weight loss or blood sugar control.
  2. It highlights the influence of pharmaceutical companies on medical advice and guidelines in the diabetes management space.
  3. The article raises concerns about financial conflicts of interest, lack of long-term efficacy data, and potential risks associated with focusing on weight loss over other health factors.
Weight and Healthcare 159 implied HN points 20 Nov 21
  1. Novo Nordisk's campaign to end weight stigma is seen as disingenuous, as they profit from selling weight loss drugs.
  2. Novo Nordisk coordinated a workshop titled 'Grand Nursing Rounds Obesity,' which perpetuated weight stigma and fat jokes in healthcare.
  3. Research shows that weight stigma is prevalent among healthcare practitioners, with a significant percentage feeling uncomfortable caring for obese patients.